Terns Pharmaceuticals, Inc. Annual Costs and Expenses in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Terns Pharmaceuticals, Inc. quarterly/annual Costs and Expenses history and growth rate from 2020 to 2023.
  • Terns Pharmaceuticals, Inc. Costs and Expenses for the quarter ending September 30, 2024 was $24.9M, a 24.8% decline year-over-year.
  • Terns Pharmaceuticals, Inc. Costs and Expenses for the twelve months ending September 30, 2024 was $100M, a 4.88% increase year-over-year.
  • Terns Pharmaceuticals, Inc. annual Costs and Expenses for 2023 was $103M, a 65.3% increase from 2022.
  • Terns Pharmaceuticals, Inc. annual Costs and Expenses for 2022 was $62M, a 22% increase from 2021.
  • Terns Pharmaceuticals, Inc. annual Costs and Expenses for 2021 was $50.9M, a 37.4% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $103M +$40.5M +65.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-14
2022 $62M +$11.2M +22% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2021 $50.9M +$13.8M +37.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-27
2020 $37M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.